COVID 19 Vaccine: Novavax Received up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing Funds clinical development of NVX-CoV2373 through Phase 2 Supports rapid scale-up of vaccine manufacturing Allows for in…
